573 related articles for article (PubMed ID: 24323580)
1. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
[TBL] [Abstract][Full Text] [Related]
2. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
Dang C; Lu Y; Chen X; Li Q
Front Immunol; 2021; 12():650708. PubMed ID: 33927721
[TBL] [Abstract][Full Text] [Related]
3. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
You Z; Timilshina M; Jeong BS; Chang JH
Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
5. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation.
Qin H; Yeh WI; De Sarno P; Holdbrooks AT; Liu Y; Muldowney MT; Reynolds SL; Yanagisawa LL; Fox TH; Park K; Harrington LE; Raman C; Benveniste EN
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5004-9. PubMed ID: 22411837
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.
Benveniste EN; Liu Y; McFarland BC; Qin H
J Interferon Cytokine Res; 2014 Aug; 34(8):577-88. PubMed ID: 25084174
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
Sci Rep; 2015 Nov; 5():17407. PubMed ID: 26616302
[TBL] [Abstract][Full Text] [Related]
9. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
10. Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.
Liu Y; Gibson SA; Benveniste EN; Qin H
Crit Rev Immunol; 2015; 35(6):505-27. PubMed ID: 27279046
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways.
Jia Y; Jing J; Bai Y; Li Z; Liu L; Luo J; Liu M; Chen H
PLoS One; 2011; 6(10):e27006. PubMed ID: 22066025
[TBL] [Abstract][Full Text] [Related]
12. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV regulates differentiation and induces apoptosis of activated CD4
Yang L; Xing F; Han X; Li Q; Wu H; Shi H; Wang Z; Huang F; Wu X
Toxicol Appl Pharmacol; 2019 Jan; 362():105-115. PubMed ID: 30385269
[TBL] [Abstract][Full Text] [Related]
14. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
[TBL] [Abstract][Full Text] [Related]
16. CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
Xia P; Gong X; Xiao L; Wang Y; Zhang T; Liao Q; Mo X; Qiu X; Huang J
Brain Behav Immun; 2018 Jul; 71():158-168. PubMed ID: 29548993
[TBL] [Abstract][Full Text] [Related]
17. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
Lee MJ; Bing SJ; Choi J; Jang M; Lee G; Lee H; Chang BS; Jee Y; Lee SJ; Cho IH
Mol Neurodegener; 2016 Jul; 11(1):54. PubMed ID: 27450563
[TBL] [Abstract][Full Text] [Related]
18. Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration.
Zhang F; Wei W; Chai H; Xie X
J Immunol; 2013 Feb; 190(3):1017-25. PubMed ID: 23267022
[TBL] [Abstract][Full Text] [Related]
19. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
20. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Kong W; Li H; Tuma RF; Ganea D
Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
